Spurgeon, S., Ribrag, V., Musteata, V., Karnabeda, O., Di, M., Gabrail, N., Murthy, G. S. G., Calustian, L., Mulvey, E., Taszner, M., Zhang, S., Yin, W., Ye, M., Basile, F., Marshall, N., Zheng, W., Yoo, B., Upalawanna, A., Dugan, M., Akinsanya, K., Ulrickson, M., Tomuleasa, C., Visco, C., Olszewski, A. (2025). SGR-1505, a potent and selective MALT1 inhibitor with preliminary efficacy in BTKi exposed Waldenström macroglobulinemia (WM) and “double-exposed” CLL/SLL. Blood. https://doi.org/10.1182/blood-2025-3603